Literature DB >> 22556263

Loss of fibroblast HIF-1α accelerates tumorigenesis.

Jung-whan Kim1, Colin Evans, Alexander Weidemann, Norihiko Takeda, Yun Sok Lee, Christian Stockmann, Cristina Branco-Price, Filip Brandberg, Gustavo Leone, Michael C Ostrowski, Randall S Johnson.   

Abstract

Solid tumors consist of malignant cells and associated stromal components, including fibroblastic cells that contribute to tumor growth and progression. Although tumor fibrosis and aberrant vascularization contribute to the hypoxia often found in advanced tumors, the contribution of hypoxic signaling within tumor-associated fibroblasts to tumorigenesis remains unknown. In this study, we used a fibroblast-specific promoter to create mice in which key hypoxia regulatory genes, including VHL, HIF-1α, HIF-2α, and VEGF-A, were knocked out specifically in tumor stromal fibroblasts. We found that loss of HIF-1α and its target gene VEGF-A accelerated tumor growth in murine model of mammary cancer. HIF-1α and VEGF-A loss also led to a reduction in vascular density and myeloid cell infiltration, which correlated with improved tumor perfusion. Together, our findings indicate that the fibroblast HIF-1α response is a critical component of tumor vascularization. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556263      PMCID: PMC4089958          DOI: 10.1158/0008-5472.CAN-12-0534

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  41 in total

1.  Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocyte-macrophages in humans.

Authors:  A Sawano; S Iwai; Y Sakurai; M Ito; K Shitara; T Nakahata; M Shibuya
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

2.  Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein.

Authors:  M Ohh; C W Park; M Ivan; M A Hoffman; T Y Kim; L E Huang; N Pavletich; V Chau; W G Kaelin
Journal:  Nat Cell Biol       Date:  2000-07       Impact factor: 28.824

3.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

4.  Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis.

Authors:  R Bos; H Zhong; C F Hanrahan; E C Mommers; G L Semenza; H M Pinedo; M D Abeloff; J W Simons; P J van Diest; E van der Wall
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

5.  Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

Authors:  Frank Winkler; Sergey V Kozin; Ricky T Tong; Sung-Suk Chae; Michael F Booth; Igor Garkavtsev; Lei Xu; Daniel J Hicklin; Dai Fukumura; Emmanuelle di Tomaso; Lance L Munn; Rakesh K Jain
Journal:  Cancer Cell       Date:  2004-12       Impact factor: 31.743

6.  Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.

Authors:  H E Ryan; M Poloni; W McNulty; D Elson; M Gassmann; J M Arbeit; R S Johnson
Journal:  Cancer Res       Date:  2000-08-01       Impact factor: 12.701

7.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

8.  Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

Authors:  Nan Tang; Lianchun Wang; Jeffrey Esko; Frank J Giordano; Yan Huang; Hans-Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cancer Cell       Date:  2004-11       Impact factor: 31.743

Review 9.  Stromal fibroblasts in cancer initiation and progression.

Authors:  Neil A Bhowmick; Eric G Neilson; Harold L Moses
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy.

Authors:  E Y Lin; A V Nguyen; R G Russell; J W Pollard
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  35 in total

1.  Hypoxic cancer-associated fibroblasts increase NCBP2-AS2/HIAR to promote endothelial sprouting through enhanced VEGF signaling.

Authors:  Fernanda G Kugeratski; Samuel J Atkinson; Lisa J Neilson; Sergio Lilla; John R P Knight; Jens Serneels; Amelie Juin; Shehab Ismail; David M Bryant; Elke K Markert; Laura M Machesky; Massimiliano Mazzone; Owen J Sansom; Sara Zanivan
Journal:  Sci Signal       Date:  2019-02-05       Impact factor: 8.192

2.  Transformation of somatic cells into stem cell-like cells under a stromal niche.

Authors:  Seung Tae Lee; Seung Pyo Gong; Kyung Eun Yum; Eun Ju Lee; Chae Hyun Lee; Jun Hee Choi; Dae Yong Kim; Hojae Han; Kye-Seong Kim; Eriona Hysolli; Ji Yeon Ahn; In-Hyun Park; Jae Yong Han; Jae-Wook Jeong; Jeong Mook Lim
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

3.  Targeting Hypoxia-Inducible Factor-1α/Pyruvate Dehydrogenase Kinase 1 Axis by Dichloroacetate Suppresses Bleomycin-induced Pulmonary Fibrosis.

Authors:  Justin Goodwin; Hyunsung Choi; Meng-Hsiung Hsieh; Michael L Neugent; Jung-Mo Ahn; Heather N Hayenga; Pankaj K Singh; David B Shackelford; In-Kyu Lee; Vladimir Shulaev; Shanta Dhar; Norihiko Takeda; Jung-Whan Kim
Journal:  Am J Respir Cell Mol Biol       Date:  2018-02       Impact factor: 6.914

Review 4.  Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?

Authors:  Yanqing Huang; Daniel Lin; Cullen M Taniguchi
Journal:  Sci China Life Sci       Date:  2017-10-13       Impact factor: 6.038

5.  Non-canonical HIF-1 stabilization contributes to intestinal tumorigenesis.

Authors:  Nadine Rohwer; Sandra Jumpertz; Merve Erdem; Antje Egners; Klaudia T Warzecha; Athanassios Fragoulis; Anja A Kühl; Rafael Kramann; Sabine Neuss; Ines Rudolph; Tobias Endermann; Christin Zasada; Ivayla Apostolova; Marco Gerling; Stefan Kempa; Russell Hughes; Claire E Lewis; Winfried Brenner; Maciej B Malinowski; Martin Stockmann; Lutz Schomburg; William Faller; Owen J Sansom; Frank Tacke; Markus Morkel; Thorsten Cramer
Journal:  Oncogene       Date:  2019-05-01       Impact factor: 9.867

Review 6.  Nanoparticles for Targeting Intratumoral Hypoxia: Exploiting a Potential Weakness of Glioblastoma.

Authors:  Mihaela Aldea; Ioan Alexandru Florian; Gabriel Kacso; Lucian Craciun; Sanda Boca; Olga Soritau; Ioan Stefan Florian
Journal:  Pharm Res       Date:  2016-05-26       Impact factor: 4.200

Review 7.  Hypoxia: Signaling the Metastatic Cascade.

Authors:  Erinn B Rankin; Jin-Min Nam; Amato J Giaccia
Journal:  Trends Cancer       Date:  2016-06-02

8.  Hypoxia-inducible factors: a central link between inflammation and cancer.

Authors:  Daniel Triner; Yatrik M Shah
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

Review 9.  The ever-expanding role of HIF in tumour and stromal biology.

Authors:  Edward L LaGory; Amato J Giaccia
Journal:  Nat Cell Biol       Date:  2016-04       Impact factor: 28.824

Review 10.  Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?

Authors:  Ellen Puré; Albert Lo
Journal:  Cancer Immunol Res       Date:  2016-04       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.